| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.00084 | 1 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00068 | 1 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.0008 | 1 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.00065 | 1 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.00061 | 1 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.00054 | 1 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | -0.00043 | 1 |